Jazz Pharmaceuticals PLC
(NASDAQ:JAZZ)
$151.00
-3.51[-2.27%]
At close: Feb 8
$151.00
After Hours: 5:01PM EDT
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Jazz Pharmaceuticals Stock (NASDAQ:JAZZ), Quotes and News Summary

Jazz Pharmaceuticals Stock (NASDAQ: JAZZ) stock price, news, charts, stock research, profile.

Loading...
Day Range151.000 - 155.03052 Wk Range125.360 - 169.980Open / Close154.870 / 151.000Float / Outstanding54.976M / 62.966M
Vol / Avg.387.047K / 561.415KMkt Cap9.508BP/E-50d Avg. Price155.540
Div / Yield (Forward)- / -%Payout Ratio-Total Float54.976MEPS-0.270
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 13, 2023, 12:22PM
Seeking Alpha - Jan 9, 2023, 4:06AM
Seeking Alpha - Jan 2, 2023, 7:10AM
Seeking Alpha - Dec 9, 2022, 3:02AM
Seeking Alpha - Dec 7, 2022, 5:00AM
Sector: Health Care.Industry: Pharmaceuticals
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Earnings

see more
Q1 2023Est.ActualSurprise
EPS
(EXPECTED)2023-05-03
REV
Q4 2022Est.ActualSurprise
EPS
(EXPECTED)2023-02-28
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Jazz Pharmaceuticals (JAZZ) stock?

A

You can purchase shares of Jazz Pharmaceuticals (NASDAQ: JAZZ) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Jazz Pharmaceuticals's (JAZZ) competitors?

A

Other companies in Jazz Pharmaceuticals’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Jazz Pharmaceuticals (JAZZ) stock?

A

The latest price target for Jazz Pharmaceuticals (NASDAQ: JAZZ) was reported by Goldman Sachs on Friday, December 9, 2022. The analyst firm set a price target for 190.00 expecting JAZZ to rise to within 12 months (a possible 25.83% upside). 17 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Jazz Pharmaceuticals (JAZZ)?

A

The stock price for Jazz Pharmaceuticals (NASDAQ: JAZZ) is $151 last updated February 8, 2023 at 9:00 PM UTC.

Q

Does Jazz Pharmaceuticals (JAZZ) pay a dividend?

A

There are no upcoming dividends for Jazz Pharmaceuticals.

Q

When is Jazz Pharmaceuticals (NASDAQ:JAZZ) reporting earnings?

A

Jazz Pharmaceuticals’s Q1 earnings are confirmed for Wednesday, May 3, 2023.

Q

Is Jazz Pharmaceuticals (JAZZ) going to split?

A

There is no upcoming split for Jazz Pharmaceuticals.

Q

What sector and industry does Jazz Pharmaceuticals (JAZZ) operate in?

A

Jazz Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.